Clinical Trials Office

The Clinical Trials Office (CTO) Shared Resource fosters a supportive environment to help members of The Ohio State University Comprehensive Cancer Center conduct clinical trials by providing a centralized resource of comprehensive management services to allow OSUCCC investigators to conduct successful clinical trials in a methodologically sound, expedient and cost-effective manner.

The CTO’s centralized clinical protocol administration includes departments specializing in protocol implementation and coordination, data and regulatory management, proficiency in negotiating clinical trial agreements and development of clinical trial budgets, internal auditing, and clinical trial education.  

The CTO maintains six specialized disease teams of study personnel:

  • Breast Cancer 
  • Hematologic Malignancy/BMT
  • Phase I / CLL
  • Gynecological Oncology
  • GI/GU, Thyroid, Neuroendocrine
  • Melanoma / Thoracic, Head and Neck, Neurological Oncology and Radiation Oncology

Medical Directors:

Steven Devine, MD
CTO Medical Director


Bhuvaneswari Ramaswamy, MD
CTO Medical Co-Director

Joyce Nancarrow Tull, MSN, BSN, RN
CTO Administrative Director

614-293-1815


Please contact us by completing the Customer Feedback Form.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu